Effect of Non-invasive Vagal Nerve Stimulation on Selected Outcomes in Central Obesity

NCT ID: NCT07341971

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-25

Study Completion Date

2026-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trans Cutanous Electric Nerve Stimulation of Auricular Vagus Nerve

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

auricular vagus stimulation

Transcutanous Electrial Nerve Stimulation

Group Type EXPERIMENTAL

Transcutanous Auricular vagus nerve stimulation

Intervention Type DEVICE

Non-invasive Auricular Vagus Stimulation

Sham

Sham Stimulation

Group Type SHAM_COMPARATOR

Sham

Intervention Type DEVICE

Non working device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcutanous Auricular vagus nerve stimulation

Non-invasive Auricular Vagus Stimulation

Intervention Type DEVICE

Sham

Non working device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sixty male
* Age ranges from 18 to 35
* All them are medically stable with no chronic disease
* waist circumference more than 90

Exclusion Criteria

* Individuals with metabolic diseases
* Individuals taking cholesterol lowering drugs, Anti-hypertensive drugs, Oral-hypoglycemic drugs
* smokers
Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lamiaa Zakaria Abd El Salam Salama

Assistant lecturer, Faculty of physical Therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nessreen G Al-Nahas, Professor

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lamiaa Z Salama, MSc

Role: CONTACT

01099793264

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/006137

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vagus Nerve Response in Gastroparesis Patients
NCT04207996 ACTIVE_NOT_RECRUITING
tVNS and Obesity-related Mechanisms
NCT06954844 ENROLLING_BY_INVITATION NA